![]() ![]() The China market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of Percent during the forecast period of 2023 through 2028. The USA market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of Percent during the forecast period of 2023 through 2028. It is a method where aÂballoon catheterÂis inserted in theÂcoronaryÂartery and the narrowed area is opened by inflating aÂballoon.ĭue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters estimated at USD 1051.7 million in the year 2022, is projected to reach a revised size of USD 1212.5 million by 2028, growing at a CAGR of 2.4Percent during the forecast period 2022-2028. PTCAÂ(percutaneous transluminal coronary angioplasty) is the main method of treatment ofÂcoronaryÂstenosis. In 2021, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon. The Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market is anticipated to rise at a considerable rate during the forecast period, between 20. Short Description About Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market: Who is the largest manufacturers of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Worldwide? ![]() This Exclusive Data Report also presents qualitative and quantitative perspectives on SWOT and PESTLE analysis based on geographical regions and industry segments. Precision Reports has published a new report titled as " Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market" by End User ( Semi-Compliant, Non-Compliant), Types ( Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter), Region and Global Forecast to 2023-2030 - Executive Data Report. A ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions: the ISAR-CALC randomised trial.The MarketWatch News Department was not involved in the creation of this content. Strategy success (91.9% vs 83.8% p=0.48) and procedural success (100% vs 89.2% p=0.12) were numerically more frequent with the super high-pressure balloon versus the scoring balloon.Ĭonclusions: In patients with severely calcified coronary artery lesions, preparation with a super high-pressure balloon versus a scoring balloon was associated with comparable stent expansion on intravascular imaging and a trend towards improved angiographic performance. ![]() ![]() After unsuccessful lesion preparation with a standard non-compliant balloon (0.99). Methods: In this randomised, open-label trial, patients with severely calcified coronary lesions were enrolled at five centres in Germany and Switzerland. Background: The comparative efficacy of balloon-based techniques to prepare severely calcified coronary lesions before stenting remains poorly studied.Īims: We sought to compare stent expansion following preparation of severely calcified coronary lesions with either a super high-pressure balloon or a scoring balloon. ![]()
0 Comments
Leave a Reply. |